Cybin (HELP) Other Operating Expenses (2020 - 2025)
Cybin (HELP) reported Other Operating Expenses of $543.45 for Q2 2025, up 100.33% on a YoY basis from $271.27 in Q2 2024, and down 100.0% quarter-over-quarter from $29.8 million in Q1 2025.
Cybin (HELP) Other Operating Expenses (2020 - 2025) Analysis & Trends
Cybin has reported Other Operating Expenses for 6 years, with the latest figure at $543.45 in Q2 2025.
- For the quarter ending Q2 2025, Other Operating Expenses rose 100.33% year-over-year to $543.45; the trailing twelve-month figure through Jun 2025 stood at $54.1 million (up 414.03% YoY), and the FY2025 full-year result was $30.8 million, up 205.1% from the prior year.
- Other Operating Expenses for Q2 2025 stood at $543.45, down from $29.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was $29.8 million in Q1 2025, with the low at -$16.6 million in Q1 2023.
- Historically, Other Operating Expenses has averaged $3.8 million across 5 years, with a median of $801129.3 in 2023.
- Annual changes were most pronounced in 2023 — Other Operating Expenses sank 161.15% — and 2024, when it soared 2942.0%.
- Cybin's Other Operating Expenses stood at $3.1 million in 2021, then slumped by 88.82% to $348460.5 in 2022, then tumbled by 161.15% to -$213068.2 in 2023, then surged by 38.97% to -$130039.7 in 2024, then jumped by 100.42% to $543.45 in 2025.
- The last three Other Operating Expenses figures came in at $543.45 (Q2 2025), $29.8 million (Q1 2025), and -$130039.7 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 543.45 |
| Mar 31, 2025 | 29.85 Mn |
| Dec 31, 2024 | -130,039.72 |
| Sep 30, 2024 | 24.37 Mn |
| Jun 30, 2024 | -163,845.67 |
| Mar 31, 2024 | 10.10 Mn |
| Dec 31, 2023 | -213,068.19 |
| Sep 30, 2023 | 801,129.32 |
| Jun 30, 2023 | 623,851.17 |
| Feb 28, 2023 | -16.60 Mn |
| Dec 31, 2022 | 348,460.49 |
| Sep 30, 2022 | 388,740.35 |
| May 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 3.90 Mn |
| Jun 30, 2021 | 3.43 Mn |
| Mar 31, 2021 | 2.77 Mn |
| Dec 31, 2020 | 3.23 Mn |
| Sep 30, 2020 | 589,833.01 |
| Jun 30, 2020 | 1.79 Mn |